Stock HIGR HI-GREAT GROUP HOLDING COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials Hi-Great Group Holding Company

Equities

HIGR

US4283711087

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 01:10:02 19/10/2022 am IST 		5-day change 1st Jan Change
0.0178 USD -98.22% Intraday chart for Hi-Great Group Holding Company -.--% -.--%
30/05 Hi-Great Group Holding Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
20/05 Hi-Great Group Holding Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 500 85 100 1.78 1.78
Enterprise Value (EV) 1 500 85.12 100 1.806 1.8
P/E ratio -23,697 x -6,693 x 1,623 x 539 x -14.6 x
Yield - - - - -
Capitalization / Revenue - 44,16,11,205 x 37,85,09,731 x 85,63,703 x 1,62,57,044 x
EV / Revenue - 44,22,26,469 x 37,85,16,662 x 86,90,826 x 1,64,44,256 x
EV / EBITDA - - - - -1,95,88,302 x
EV / FCF - 6,37,30,47,619 x 1,46,11,60,593 x -2,20,69,651 x 11,27,14,286 x
FCF Yield - 0% 0% -0% 0%
Price to Book -25,00,000 x -6,538 x 1,603 x 292 x -16.3 x
Nbr of stocks (in thousands) 1,00,000 1,00,000 1,00,000 1,00,000 1,00,000
Reference price 2 5.000 0.8500 1.000 0.0178 0.0178
Announcement Date 24/02/22 24/02/22 12/07/22 17/04/23 20/05/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales - 0.1925 0.2642 0.2079 0.1095
EBITDA - - - - -0.0919
EBIT 1 -0.0208 -0.0113 0.062 0.003299 -0.1195
Operating Margin - -5.85% 23.46% 1.59% -109.12%
Earnings before Tax (EBT) 1 -0.0179 -0.012 0.0617 0.0033 -0.1218
Net income 1 -0.0179 -0.0128 0.0617 0.0033 -0.1218
Net margin - -6.64% 23.34% 1.59% -111.2%
EPS 2 -0.000211 -0.000127 0.000616 0.000033 -0.001217
Free Cash Flow - 0.0134 0.0684 -0.0819 0.016
FCF margin - 6.94% 25.91% -39.38% 14.59%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - 110.99% - -
Dividend per Share - - - - -
Announcement Date 24/02/22 24/02/22 12/07/22 17/04/23 20/05/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 0 0.12 0 0.03 0.02
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - - - - -0.223 x
Free Cash Flow - 0.01 0.07 -0.08 0.02
ROE (net income / shareholders' equity) - 193% 250% 59.9% 236%
ROA (Net income/ Total Assets) - -6.86% 15.9% 0.87% -56.1%
Assets 1 - 0.1863 0.3888 0.3781 0.2171
Book Value Per Share 2 -0 -0 0 0 -0
Cash Flow per Share 2 0 0 0 0 0
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 24/02/22 24/02/22 12/07/22 17/04/23 20/05/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
HI-GREAT GROUP HOLDING COMPANY Stock Hi-Great Group Holding Company
-.--% 17.8L
MODERNA, INC. Stock Moderna, Inc.
+19.41% 4.55TCr
LONZA GROUP AG Stock Lonza Group AG
+38.65% 3.81TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.62% 3.85TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+26.95% 3.07TCr
CELLTRION, INC. Stock Celltrion, Inc.
-13.50% 2.6TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.74% 2.59TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+44.87% 1.41TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+34.36% 1.27TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-7.14% 1.13TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. HIGR Stock
  4. Financials Hi-Great Group Holding Company